Alembic Pharmaceuticals has converted its branch office into a Wholly Owned Subsidiary (WOS) named Alembic Pharmaceuticals Scientific Office L.L.C. The company has completed all necessary requirements for the conversion, including regulatory approvals, and is effective as of November 6, 2025. The subsidiary is incorporated in the United Arab Emirates.
New Subsidiary Establishment
Alembic Pharmaceuticals has announced the conversion of its branch office into a Wholly Owned Subsidiary (WOS). This new entity will operate under the name Alembic Pharmaceuticals Scientific Office L.L.C.
Details of the Subsidiary
The newly formed subsidiary is incorporated in the United Arab Emirates. The consideration for the acquisition of this new entity is AED 50,000 (Arab Emirates Dirhams Fifty Thousand), reflecting complete ownership by Alembic Pharmaceuticals. With this establishment, Alembic Pharmaceuticals now has a dedicated scientific office operating in the UAE.
Operational Aspects
The Dep. of Economic Development, Government of Dubai, has granted the necessary licenses for the operation of the subsidiary. The Subsidiary holds 100% shareholding and control. This intimation pertains to a newly incorporated entity.
Source: BSE
